Durability of NEDA-3 in Patients Receiving Cladribine Tablets
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Durability of no evidence of disease activity-3 (NEDA-3) in patients receiving cladribine tablets: The CLARITY extension study
Mult. Scler. 2021 Oct 12;[EPub Ahead of Print], G Giovannoni, BA Singer, D Issard, D Jack, P VermerschFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.